DV
Dividend Vision

FEED — ENvue Medical Inc.

ENvue Medical Inc. (FEED)

Total return is -100.0% over the past 11.2 years, 440.4 points behind SPY at 340.4%. Its deepest 1-year drawdown was 97.0%.

ENvue Medical develops non-invasive, ultrasound-based medical devices for biofilm prevention, pain therapy, and wound healing, including products like UroShield for urinary catheter management, PainShield for pain treatment, and WoundShield for tissue regeneration. The company sells directly to patients and through distributors across the United States, Europe, Australia, Israel, New Zealand, and other markets. ENvue Medical does not currently distribute to shareholders.

FEED key facts

Asset type
Stock
Asset class
Equity
Inception date
05/28/2015
Last close
$0.44
Market cap
$2,533,596
Average volume
882500.0
Beta
1.559
Payout ratio
0.0
Forward P/E
0.0
EPS
$-3.67